ArticleHealth economics2018
Estimating the opportunity costs of bed-days.
Article in Health economics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 46 citations in OpenAlex.
- Estimating the Value of Combination Vaccines: A Methodological Framework.PharmacoEconomics · 2026Review
- Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.Cost effectiveness and resource allocation : C/E · 2026Article
- Perspectives on the economic costs of disease outbreaks to health systems.The Pan African medical journal · 2026Article
- Article
- A Cost of Illness Analysis of Children with Encephalitis Presenting to a Major Hospital in Vietnam.The American journal of tropical medicine and hygiene · 2025Observational
- On spillovers in economic evaluations: definition, mapping review and research agenda.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Review
- Article
- Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?Applied health economics and health policy · 2024Article
- Safety and cost of performing laparoscopic sleeve gastrectomy with same day discharge at a large academic hospital.Surgical endoscopy · 2024Article
- Cost analysis of outpatient services for major external structural birth defects: an ingredient approach in selected hospitals in Kiambu County, Kenya.The Pan African medical journal · 2024Article
- Birth defects and their impact on child morbidity and mortality in developing settings.The Pan African medical journal · 2024Article
- What are economic costs and when should they be used in health economic studies?Cost effectiveness and resource allocation : C/E · 2023Review
- Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?Vaccines · 2023Article
- Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.Vaccines · 2023Article
- Costs of two vancomycin-resistant enterococci outbreaks in an academic hospital.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review.Health economics review · 2022Article
- Direct Medical Costs of Tetanus, Dengue, and Sepsis Patients in an Intensive Care Unit in Vietnam.Frontiers in public health · 2022Article
- Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic.PharmacoEconomics · 2021Article
- How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021Article
- The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.The Lancet. Infectious diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opportunity costs of bed-days are fundamental to understanding the value of healthcare systems. They greatly influence burden of disease estimations and economic evaluations involving stays in healthcare facilities. However, different estimation techniques employ assumptions that differ crucially in whether to consider the value of the second-best alternative use forgone, of any available alternative use, or the value of the actually chosen alternative. Informed by economic theory, this paper provides a taxonomic framework of methodologies for estimating the opportunity costs of resources. This taxonomy is then applied to bed-days by classifying existing approaches accordingly. We highlight differences in valuation between approaches and the perspective adopted, and we use our framework to appraise the assumptions and biases underlying the standard approaches that have been widely adopted mostly unquestioned in the past, such as the conventional use of reference costs and administrative accounting data. Drawing on these findings, we present a novel approach for estimating the opportunity costs of bed-days in terms of health forgone for the second-best patient, but expressed monetarily. This alternative approach effectively re-connects to the concept of choice and explicitly considers net benefits. It is broadly applicable across settings and for other resources besides bed-days.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.